Posts by: Ana Belo van Wijk, PhD

Treatment with Esbriet (pirfenidone) significantly reduced cough by 34 percent in patients with idiopathic pulmonary fibrosis (IPF), along with cough severity, a new 12-week study shows. The study, “Effect of pirfenidone ... Read more

November 6, 2017November 6, 2017

Dogs May Help Protect Children Against Asthma and Eczema, Studies Shows

Asthma, News

It’s not as if dog lovers needed more reasons to appreciate their furry friends. But researchers have discovered in two separate studies that dogs can help protect children against asthma, ... Read more

October 25, 2017October 25, 2017

Global Blood Therapeutics Scraps Its Effort to Develop GBT440 as a Treatment for IPF

Idiopathic Pulmonary Fibrosis, News

Disappointing clinical trial results have prompted Global Blood Therapeutics to scrap its program to develop GBT440 as a treatment for idiopathic pulmonary fibrosis. GBT440 increased patients’ lung oxygen levels, but not enough ... Read more

September 27, 2017September 27, 2017

Collaboration Will Raise IPF Awareness, Reward Best Ideas for Improving Quality of Life

News

The American Lung Association and Three Lakes Partners will collaborate to increase awareness about idiopathic pulmonary fibrosis (IPF) and reward big ideas to improve patients’ quality of life. The partnership was announced ... Read more

September 25, 2017September 25, 2017

Promising New Diagnostic Tool May Accurately Predict Survival of IPF Patients

News

The expression of 52 genes can accurately predict the survival of individual idiopathic pulmonary fibrosis (IPF) patients, a new study confirms. This could improve treatment approaches and aid in management ... Read more